Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Comparing two breathing methods during endoscopy of the pharynx, larynx, and oesophagus

Official title: OPTIGO /Comparison of Two Ventilation Methods During Endoscopy of the Pharynx, Larynx and Oesophagus: Multicentre, Randomised, Non-inferiority Trial

Run by Poitiers University Hospital · NCT07004699 · Data updated 2026-11-12

It will test whether keeping adults breathing on their own with high-flow oxygen or using standard ventilation makes endoscopy of the throat and oesophagus safer and easier.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment610 (estimated)
SponsorPoitiers University Hospital
Academic / other
Locations3 sites (La Roche-sur-Yon and 2 other locations)
StatusRecruiting
StartedJuly 11, 2025
Main results expectedJuly 1, 2027
Study endsJuly 1, 2027
Registry record updatedAugust 31, 2026
Trial IDNCT07004699 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) who do not require supplemental oxygen and are scheduled for an exclusive endoscopy of the pharynx, larynx and oesophagus and can give informed consent.

Probably not a fit

Patients having combined procedures, with BMI ≥35, stage IV COPD, or known allergy to remifentanil, propofol, or lidocaine are excluded and unlikely to benefit from the tested ventilation strategies.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults scheduled for an exclusive endoscopy of the pharynx, larynx and oesophagus at CHU de Poitiers will be assigned to one of two ventilation strategies during the procedure: spontaneous ventilation supported by high-flow oxygen or conventional ventilation under general anaesthesia. The trial monitors intraoperative oxygenation, airway visibility, procedural conditions and immediate safety outcomes. Patients with combined procedures, severe obesity, or advanced COPD are excluded to reduce risk and improve comparability. Results will show whether one method provides better visibility and safety during these diagnostic or therapeutic endoscopies.

Why it matters

Potential benefit: If successful, the tested approach could improve airway visibility and oxygen safety during endoscopy and may reduce the need for more invasive ventilation for some patients.

How similar studies have gone: High-flow nasal oxygen and spontaneous ventilation have been used in airway procedures with promising oxygenation and visibility results, but direct comparative evidence remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient aged 18 or over.
* Scheduled for upper aerodigestive tract endoscopy (pharynx, larynx, oesophagus).
* ASA physical status I to IV.
* No requirment for preoperative supplemental oxygen.
* Informed consent signed.

Exclusion Criteria:

* Endoscopy combined with another procedure.
* Body mass index ≥ 35 kg/m².
* Severe chronic obstructive pulmonary disease (GOLD stage IV).
* Allergy to one of the anaesthetic agents (remifentanil, propofol, lidocaine).
* Baseline SpO2 ≤ 92% on arrival in the operating room

Where it's running

  • CHD Vendée
    La Roche-sur-Yon, France
    Recruiting
  • CHU Limoges
    Limoges, France
    Recruiting
  • CHU Poitiers
    Poitiers, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.